Apnimed Secures Up to $150MM in Debt Financing with HealthCare Royalty Partners
Apnimed, a pharmaceutical company developing novel oral therapies for obstructive sleep apnea (OSA), entered into a senior secured credit facility for up to $150 million with funds managed by HealthCare Royalty Partners (HCRx). The capital is expected to support commercial...
Read moreDetails










